BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19507407)

  • 1. Vitamin C with metabolites reduce oxalate levels compared to ascorbic acid: a preliminary and novel clinical urologic finding.
    Moyad MA; Combs MA; Crowley DC; Baisley JE; Sharma P; Vrablic AS; Evans M
    Urol Nurs; 2009; 29(2):95-102. PubMed ID: 19507407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin C with metabolites: additional analysis suggests favorable changes in oxalate.
    Moyad MA; Combs MA; Baisley JE; Evans M
    Urol Nurs; 2009; 29(5):383-5. PubMed ID: 19863045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vitamin C and stone risk. Review of the literature].
    Traxer O; Pearle MS; Gattegno B; Thibault P
    Prog Urol; 2003 Dec; 13(6):1290-4. PubMed ID: 15000301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A critical analysis of the role of gut Oxalobacter formigenes in oxalate stone disease.
    Siva S; Barrack ER; Reddy GP; Thamilselvan V; Thamilselvan S; Menon M; Bhandari M
    BJU Int; 2009 Jan; 103(1):18-21. PubMed ID: 19021605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status.
    Thamilselvan S; Menon M
    BJU Int; 2005 Jul; 96(1):117-26. PubMed ID: 15963133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.
    Zerwekh JE; Odvina CV; Wuermser LA; Pak CY
    J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hyperoxaluria and renal calculi].
    Buño Soto A; Torres Jiménez R; García Puig J; Mateos Antón F
    Arch Esp Urol; 1996 Sep; 49(7):707-26. PubMed ID: 9020008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin C metabolites, independent of smoking status, significantly enhance leukocyte, but not plasma ascorbate concentrations.
    Moyad MA; Combs MA; Vrablic AS; Velasquez J; Turner B; Bernal S
    Adv Ther; 2008 Oct; 25(10):995-1009. PubMed ID: 18836692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin C-lipid metabolites: uptake and retention and effect on plasma C-reactive protein and oxidized LDL levels in healthy volunteers.
    Pancorbo D; Vazquez C; Fletcher MA
    Med Sci Monit; 2008 Nov; 14(11):CR547-51. PubMed ID: 18971870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic role of phycocyanin: a study of oxalate mediated renal cell injury.
    Farooq SM; Asokan D; Kalaiselvi P; Sakthivel R; Varalakshmi P
    Chem Biol Interact; 2004 Aug; 149(1):1-7. PubMed ID: 15294440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up.
    Taylor EN; Stampfer MJ; Curhan GC
    J Am Soc Nephrol; 2004 Dec; 15(12):3225-32. PubMed ID: 15579526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dietary changes on urinary oxalate excretion and calcium oxalate supersaturation in patients with hyperoxaluric stone formation.
    Penniston KL; Nakada SY
    Urology; 2009 Mar; 73(3):484-9. PubMed ID: 19118878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary hyperoxaluria.
    Scheinman JI
    Miner Electrolyte Metab; 1994; 20(6):340-51. PubMed ID: 7783696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of urinary oxalate by combined calcium and citrate administration without increase in urinary calcium oxalate stone formers.
    Ito H; Suzuki F; Yamaguchi K; Nishikawa Y; Kotake T
    Clin Nephrol; 1992 Jan; 37(1):14-8. PubMed ID: 1541059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diet to reduce mild hyperoxaluria in patients with idiopathic calcium oxalate stone formation: a pilot study.
    Nouvenne A; Meschi T; Guerra A; Allegri F; Prati B; Fiaccadori E; Maggiore U; Borghi L
    Urology; 2009 Apr; 73(4):725-30, 730.e1. PubMed ID: 19193409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperoxaluria in kidney stone formers treated with modern bariatric surgery.
    Asplin JR; Coe FL
    J Urol; 2007 Feb; 177(2):565-9. PubMed ID: 17222634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study of the intake of vitamins C and B6, and the risk of kidney stones in men.
    Curhan GC; Willett WC; Rimm EB; Stampfer MJ
    J Urol; 1996 Jun; 155(6):1847-51. PubMed ID: 8618271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substituting milk for apple juice does not increase kidney stone risk in most normocalciuric adults who form calcium oxalate stones.
    Massey LK; Kynast-Gales SA
    J Am Diet Assoc; 1998 Mar; 98(3):303-8. PubMed ID: 9508013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxalate metabolism in renal stone disease with special reference to calcium metabolism and intestinal absorption.
    Lindsjö M
    Scand J Urol Nephrol Suppl; 1989; 119():1-53. PubMed ID: 2669121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diets with either beef or plant proteins reduce risk of calcium oxalate precipitation in patients with a history of calcium kidney stones.
    Massey LK; Kynast-Gales SA
    J Am Diet Assoc; 2001 Mar; 101(3):326-31. PubMed ID: 11269613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.